13th Biennial Ovarian Cancer Research Symposium

The goal of the symposium is to bring together clinicians and researchers from across many disciplines and institutions worldwide in order to encourage collaborations toward advancing the field of ovarian cancer research. The conference seeks to enhance the understanding and knowledge of ovarian cancer, especially among junior investigators, discuss the most recent innovations in the field of ovarian cancer research, and address pressing concerns of the leaders in the clinical and research community.

SESSION TOPICS
Educational Session: Clinical Management of Ovarian Cancer for Scientists
Rare Tumors
Model Systems
Prevention and Early Detection
DNA Repair and Mechanisms
Immuno-oncology
Novel Therapeutics

SYMPOSIUM CO-CHAIRS
Douglas Levine, MD (NYU Langone)
Ursula Matulonis, MD (Dana-Farber Cancer Institute)
Barbara Norquist, MD (University of Washington)
Kunle Odunsi, MD/PhD (Roswell Park Comprehensive Cancer Center)

Continuing Medical Education Activity – AMA PRA Category 1 CreditsTM will be available.

Symposium Location Information

Hyatt Regency Seattle
808 Howell St, Seattle, WA 98101

 

Important Dates

  • March 2, 2020: Abstract Submissions Open
  • April 1, 2020: Online Registration Opens
  • July 13, 2020: Abstract Submissions Close
  • August 3, 2020: Abstract Notifications
  • September 10, 2020: Online Registration Closes (Onsite registration limited to availability)

The 13th Biennial Ovarian Cancer Research Symposium is presented by the Rivkin Center and the American Association for Cancer Research.